Insmed INSM
NASDAQ INSM
$108.72 +0.13 (+0.12%)
As of: Oct 2, 2026 · 1:17 PM EDT

Insmed (INSM) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Insmed's Depreciation & Amortization (CF) came in at $3.18 million for Q2 2026, up 28.0% from $2.48 million a year earlier and up 8.4% from the prior quarter.

Analysis

Insmed (INSM) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Insmed reported Depreciation & Amortization (CF) of $12.2 million, up 66.1% year-over-year; for FY2025, it came in at $10.45 million, up 74.2% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last three years, with a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $6 million in FY2024 (+8.6%), $5.53 million in FY2023 (+4.3%), $5.3 million in FY2022 (-41.9%) and $9.13 million in FY2021 (-0.2%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $851,000 (Q3 2022) to $3.62 million (Q4 2025).
  • Year-over-year, Depreciation & Amortization (CF) has increased for seven consecutive quarters, with growth averaging 47.9% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2025 (growth of 138.9%), and the weakest in Q3 2022 (a decline of 62.0%).
  • Business Quant data shows INSM's Depreciation & Amortization (CF) at $2.93 million (Q1 2026), $3.62 million (Q4 2025) and $2.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Insmed 24.91 Bn 19.42 Bn 358.27 Mn 3.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18 Mn
Mar 31, 2026 2.93 Mn
Dec 31, 2025 3.62 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.48 Mn
Mar 31, 2025 1.88 Mn
Dec 31, 2024 1.52 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 1.48 Mn
Sep 30, 2023 1.49 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.25 Mn
Dec 31, 2022 2.21 Mn
Sep 30, 2022 851,000.00
Jun 30, 2022 958,000.00
Mar 31, 2022 1.29 Mn
Dec 31, 2021 2.12 Mn
Sep 30, 2021 2.24 Mn
API Access

Insmed Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INSM&period=max&api_key=YOUR_API_KEY